Adirondack Trust CO Geron Corp Transaction History

Adirondack Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$1.01 - $1.83 $5,050 - $9,150	-5,000 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$0.98 - $1.85 $2,940 - $5,550	3,000 Added 150.0%	5,000 $5,000
Q3 2018 Oct 22, 2018	SELL	$1.76 - $6.38 $2,200 - $7,975	-1,250 Reduced 38.46%	2,000 $4,000
Q2 2018 Jul 26, 2018	BUY	$3.29 - $4.82 $10,692 - $15,665	3,250 New	3,250 $11,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

Stay updated on Adirondack Trust CO with notifications on news.